{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:35:38Z","timestamp":1777887338759,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG6M0091"],"award-info":[{"award-number":["CMRPG6M0091"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jocd.2026.101672","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:16:01Z","timestamp":1769040961000},"page":"101672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential predictive value of FRAX Hip and major osteoporotic fracture probabilities for denosumab response"],"prefix":"10.1016","volume":"29","author":[{"given":"Wei-Cheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Tung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Fu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-2900","authenticated-orcid":false,"given":"Ying-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jocd.2026.101672_bib0001","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","article-title":"High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study","volume":"39","author":"Angeli","year":"2006","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncpendmet0372","article-title":"Is long-term glucocorticoid therapy associated with a high prevalence of asymptomatic vertebral fractures?","volume":"3","author":"Weinstein","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2026.101672_bib0004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2026.101672_bib0005","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.2832","article-title":"Impact of the U.S. Food and drug administration's safety-related announcements on the use of bisphosphonates after hip fracture","volume":"31","author":"Kim","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"6937","key":"10.1016\/j.jocd.2026.101672_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0007","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","article-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","volume":"11","author":"Delmas","year":"2008","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0009","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jocd.2026.101672_bib0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jocd.2026.101672_bib0011","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2026.101672_bib0012","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"9886","key":"10.1016\/j.jocd.2026.101672_bib0013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jocd.2026.101672_bib0014","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"Suppl:S19-27","key":"10.1016\/j.jocd.2026.101672_bib0015","article-title":"International society for clinical densitometry position development p, scientific advisory C. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians?","volume":"5","author":"Binkley","year":"2002","journal-title":"J Clin Densitom"},{"issue":"9319","key":"10.1016\/j.jocd.2026.101672_bib0016","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0017","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/joim.12369","article-title":"Osteoporosis: the evolution of a diagnosis","volume":"277","author":"Lorentzon","year":"2015","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0018","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0019","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","article-title":"Epidemiology of fractures in England and Wales","volume":"29","author":"van Staa","year":"2001","journal-title":"Bone."},{"issue":"4","key":"10.1016\/j.jocd.2026.101672_bib0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.2002.17.4.716","article-title":"Incidence of vertebral fracture in Europe: results from the european prospective OsteoporosisStudy (EPOS)","volume":"17","author":"European Prospective Osteoporosis Study","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0021","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00223-004-0287-6","article-title":"Epidemiology of osteoporosis and fracture in men","volume":"75","author":"Kanis","year":"2004","journal-title":"Calcif Tissue Int"},{"issue":"7041","key":"10.1016\/j.jocd.2026.101672_bib0022","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"issue":"9527","key":"10.1016\/j.jocd.2026.101672_bib0023","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jocd.2026.101672_bib0024","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","article-title":"The association of radiographically detected vertebral fractures with back pain and function: a prospective study","volume":"128","author":"Nevitt","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jocd.2026.101672_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00198-017-4296-5","article-title":"Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women","volume":"29","author":"Johansson","year":"2018","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2026.101672_bib0026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00198-002-1316-9","volume":"14","author":"Hasserius","year":"2003","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0027","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jocd.2026.101672_bib0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF01623276","article-title":"Consequences of a hip fracture: a prospective study over 1 year","volume":"3","author":"Sernbo","year":"1993","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2026.101672_bib0029","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jocd.2026.101672_bib0030","unstructured":"(FRAX). CfMBDUoSFRAT. cited 2019 October"},{"issue":"5","key":"10.1016\/j.jocd.2026.101672_bib0031","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jocd.2026.101672_bib0032","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jocd.2026.101672_bib0033","series-title":"NCGlftPaTo","year":"2019"},{"issue":"6","key":"10.1016\/j.jocd.2026.101672_bib0034","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/jc.2010-2784","article-title":"Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk","volume":"96","author":"Boonen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jocd.2026.101672_bib0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2026.101672_bib0036","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11657-017-0371-y","article-title":"Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis: Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis","volume":"12","author":"Nakamura","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"2","key":"10.1016\/j.jocd.2026.101672_bib0037","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-012-1984-z","article-title":"Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan","volume":"24","author":"Soong","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2026.101672_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bone.2015.02.013","article-title":"Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010)","volume":"75","author":"Kim","year":"2015","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jocd.2026.101672_bib0039","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3346\/jkms.2010.25.11.1657","article-title":"Determination of an applicable FRAX model in Korean women","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"8","key":"10.1016\/j.jocd.2026.101672_bib0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3346\/jkms.2014.29.8.1082","article-title":"The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.jocd.2026.101672_bib0041","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11914-010-0032-1","article-title":"The utility and limitations of FRAX: A US perspective","volume":"8","author":"Silverman","year":"2010","journal-title":"Curr Osteoporos Rep"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695026000041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695026000041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:08:48Z","timestamp":1777608528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695026000041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1094695026000041"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101672","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential predictive value of FRAX Hip and major osteoporotic fracture probabilities for denosumab response","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}],"article-number":"101672"}}